Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Swedish TLV’s last call for the ongoing theme survey submissions for orderly introduction for medical technologies

The Swedish Dental and Pharmaceutical Benefits Agency (TLV) is currently performing a theme survey for medical technology products for ischemic heart disease and heart failure.

Theme surveys are part of TLV’s horizon scanning work which identifies new and innovative technologies that may become important for Swedish healthcare. Horizon scanning commissioned by the Medical Technology Product (MTP) Council is the first step of the national Orderly Introduction process for new MedTech products.

As of August 2020, there is one ongoing theme survey – in the areas of ischemic heart disease and heart failure. The purpose is to map the medical technology development in the field and to identify new medical devices that may be important for healthcare in the next few years, with a focus on medical devices in diagnostics and monitoring (including home monitoring).

Manufacturers of medical devices have an opportunity to notify TLV about a new product related to the theme of the survey.

Examples of information that can be provided are:

  • Suggestions for interesting products
  • Ongoing clinical studies
  • Innovation projects

Submissions can be sent via email with registration number 1769/2020.

The deadline for current submissions is August 21, 2020.

See more information in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.